Cargando…

Genome doubling shapes the evolution and prognosis of advanced cancers

Ploidy abnormalities are a hallmark of human cancers, but their impact on the evolution and outcomes of cancers is unknown. Here, we identified whole-genome doubling (WGD) in the tumors of nearly 30% of 9,692 prospectively sequenced advanced cancer patients. WGD varied by tumor lineage and molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bielski, Craig M., Zehir, Ahmet, Penson, Alexander V., Donoghue, Mark T.A., Chatila, Walid, Armenia, Joshua, Chang, Matthew T., Schram, Alison M., Jonsson, Philip, Bandlamudi, Chaitanya, Razavi, Pedram, Iyer, Gopa, Robson, Mark E., Stadler, Zsofia K., Schultz, Nikolaus, Baselga, Jose, Solit, David B., Hyman, David M., Berger, Michael F., Taylor, Barry S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072608/ https://www.ncbi.nlm.nih.gov/pubmed/30013179 http://dx.doi.org/10.1038/s41588-018-0165-1

Ejemplares similares

The context-specific role of germline pathogenicity in tumorigenesis
por: Srinivasan, Preethi, et al.
Publicado: (2021)

Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation
por: Mathur, Deepti, et al.
Publicado: (2022)

Discovery through clinical sequencing in oncology
por: Donoghue, Mark T.A., et al.
Publicado: (2020)

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
por: Murciano-Goroff, Yonina R., et al.
Publicado: (2022)

Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome
por: Donahue, Timothy F., et al.
Publicado: (2018)

Phase and context shape the function of composite oncogenic mutations
por: Gorelick, Alexander N., et al.
Publicado: (2020)

“Primary” and “secondary” muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
por: Pietzak, Eugene J., et al.
Publicado: (2019)

Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology
por: Tao, Jessica J., et al.
Publicado: (2019)

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
por: Way, Gregory P., et al.
Publicado: (2018)

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer
por: Pietzak, Eugene J., et al.
Publicado: (2022)

AKT mutant allele-specific activation dictates pharmacologic sensitivities
por: Shrestha Bhattarai, Tripti, et al.
Publicado: (2022)

Picking the Right Patient for Human Epidermal Growth Factor Receptor 3–Targeted Therapy in Platinum-Resistant Ovarian Cancer
por: Schram, Alison M., et al.
Publicado: (2016)

Precision oncology: Charting a path forward to broader deployment of genomic profiling
por: Schram, Alison M., et al.
Publicado: (2017)

Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion
por: Rao, Thapi D., et al.
Publicado: (2015)

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020)

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
por: Tsui, Dana W. Y., et al.
Publicado: (2021)

Retained Mismatch Repair Protein Expression Occurs in Approximately 6% of Microsatellite Instability-High Cancers and is Associated with Missense Mutations in Mismatch Repair Genes.
por: Hechtman, Jaclyn F., et al.
Publicado: (2019)

Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
por: Mandelker, Diana, et al.
Publicado: (2023)

NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
por: Belhadj, Sami, et al.
Publicado: (2023)

The long tail of oncogenic drivers in prostate cancer
por: Armenia, Joshua, et al.
Publicado: (2018)

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors
por: Nigam, Aradhya, et al.
Publicado: (2023)

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
por: Chandran, Smita S., et al.
Publicado: (2022)

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
por: Clinton, Timothy N., et al.
Publicado: (2022)

Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis
por: Vedanayagam, Jeffrey, et al.
Publicado: (2019)

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
por: Smyth, Lillian M., et al.
Publicado: (2021)

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience
por: Crist, Michael, et al.
Publicado: (2019)

Comparing the Rate of Regression after Conductive Keratoplasty with or without Prior Laser-Assisted in situ Keratomileusis or Photorefractive Keratectomy
por: Moshirfar, Majid, et al.
Publicado: (2012)

Acetylated Thioredoxin Reductase 1 Resists Oxidative Inactivation
por: Wright, David. E., et al.
Publicado: (2021)

Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors
por: Rosen, Ezra Y., et al.
Publicado: (2019)

Unifying cancer and normal RNA sequencing data from different sources
por: Wang, Qingguo, et al.
Publicado: (2018)

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
por: Smith, Alison E., et al.
Publicado: (2021)

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
por: Chatila, Walid K., et al.
Publicado: (2023)

Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients
por: Zehir, Ahmet, et al.
Publicado: (2017)

Towards Automation of Germline Variant Curation in Clinical Cancer Genetics
por: Ravichandran, Vignesh, et al.
Publicado: (2019)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers
por: Hyman, David M., et al.
Publicado: (2018)

Early TP53 Alterations Shape Gastric and Esophageal Cancer Development
por: Sahgal, Pranshu, et al.
Publicado: (2021)

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
por: Chandarlapaty, Sarat, et al.
Publicado: (2009)

Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor
por: Juric, Dejan, et al.
Publicado: (2014)

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours
por: Schram, Alison M., et al.
Publicado: (2018)

Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
por: Goldsmith, David R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m9gn2sg5dcn3ugvlqmf0kdlvdt